Costa, Guido
Cavinato, Lara
Fiz, Francesco
Sollini, Martina
Chiti, Arturo
Torzilli, Guido
Ieva, Francesca
Viganò, Luca http://orcid.org/0000-0002-4108-4832
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (2019−23822)
Article History
Received: 30 May 2022
Revised: 20 February 2023
Accepted: 21 February 2023
First Online: 27 February 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Humanitas Research Hospital (protocol #83/20).
: Because of the retrospective design of the study, specific written informed consent was waived by the Institutional Review Board.
: No individual details, images or videos are included in the present manuscript. Accordingly, no informed consent for publication of the images was needed.
: We state that there are no personal conflicts of interest of any of the authors pertinent to the present manuscript. Considering the conflicts of interest in general, we state that: Luca Viganò received speaker’s honoraria from Johnson & Johnson. Arturo Chiti received speaker’s honoraria from the following companies: Advanced Accelerator Applications, General Electric Healthcare, Sirtex Medical Europe, AmGen Europe, travel grants form General Electric Healthcare and Sirtex Medical Europe; he is a member of Blue Earth Diagnostics’ and Advanced Accelerator Applications’ advisory boards and received scientific support, in terms of a three-year Ph.D. fellowship, from the Sanofi Genzyme. Francesco Fiz acts as a consultant for the MSD Sharp & Dohme GmbH (LLC).